Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Accolade, Inc. Stock Research

ACCD

10.47USD-0.11(-1.04%)Market Closed
Watchlist

Market Summary

USD10.47-0.11
Market Closed
-1.04%

ACCD Stock Price

ACCD RSI Chart

ACCD Valuation

Market Cap

796.3M

Price/Earnings (Trailing)

-5.13

Price/Sales (Trailing)

2.15

EV/EBITDA

-4.62

Price/Free Cashflow

-24.88

ACCD Price/Sales (Trailing)

ACCD Profitability

EBT Margin

-127.57%

Return on Equity

-97.02%

Return on Assets

-50.9%

Free Cashflow Yield

-4.02%

ACCD Fundamentals

ACCD Revenue

Revenue (TTM)

370.8M

Revenue Y/Y

9%

Revenue Q/Q

-5.86%

ACCD Earnings

Earnings (TTM)

-155.2M

Earnings Y/Y

88.8%

Earnings Q/Q

-26.21%

Price Action

52 Week Range

6.8317.01
(Low)(High)

Last 7 days

-1.7%

Last 30 days

-22.3%

Last 90 days

-21.5%

Trailing 12 Months

-15.5%

ACCD Financial Health

Current Ratio

3.06

ACCD Investor Care

Shares Dilution (1Y)

7.92%

Diluted EPS (TTM)

-2.12

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for ACCD

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-19
Barnes Stephen H.
sold
-1,429
11.81
-121
chief financial officer
2023-09-19
SINGH RAJEEV
sold
-4,464
11.81
-378
chief executive officer
2023-09-19
Cavanaugh Robert N
sold
-1,854
11.81
-157
president
2023-09-18
Cavanaugh Robert N
acquired
-
-
510
president
2023-09-18
HILTON MICHAEL W
acquired
-
-
332
-
2023-09-18
SINGH RAJEEV
acquired
-
-
933
chief executive officer
2023-09-18
Barnes Stephen H.
acquired
-
-
414
chief financial officer
2023-09-12
Barnes Stephen H.
sold
-2,923
13.227
-221
chief financial officer
2023-09-12
SINGH RAJEEV
sold
-8,756
13.227
-662
chief executive officer
2023-09-12
Cavanaugh Robert N
sold
-2,843
13.227
-215
president

1–10 of 50

Which funds bought or sold ACCD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-21
Jefferies Group LLC
reduced
-8.58
125,916
432,350
-%
2023-09-21
Baystate Wealth Management LLC
unchanged
-
-102
1,509
-%
2023-09-20
BARCLAYS PLC
reduced
-0.88
-37,000
456,000
-%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-23.86
-26,774
66,595
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
1.46
-55,939
1,072,160
-%
2023-08-17
Orion Portfolio Solutions, LLC
reduced
-6.1
-121,130
884,952
0.01%
2023-08-16
Nuveen Asset Management, LLC
added
41.34
3,839,340
15,693,300
-%
2023-08-15
WELLS FARGO & COMPANY/MN
added
85.02
178,964
423,096
-%
2023-08-15
ALLIANCEBERNSTEIN L.P.
unchanged
-
-68,334
1,011,490
-%
2023-08-15
LAZARD ASSET MANAGEMENT LLC
added
0.94
-91,000
1,569,000
-%

1–10 of 36

Latest Funds Activity

Are funds buying ACCD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ACCD
No. of Funds

Schedule 13G FIlings of Accolade

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
bellevue group ag
5.1%
3,677,277
SC 13G
Feb 09, 2023
vanguard group inc
6.83%
4,916,397
SC 13G/A
Feb 09, 2023
brown advisory inc
6.9%
4,988,021
SC 13G
Jan 31, 2023
blackrock inc.
7.3%
5,265,682
SC 13G/A
Jan 06, 2023
jpmorgan chase & co
7.2%
5,196,148
SC 13G
Feb 14, 2022
andreessen horowitz fund iv, l.p.
2.4%
1,619,088
SC 13G/A
Feb 09, 2022
ark investment management llc
7.54%
5,029,148
SC 13G
Feb 09, 2022
vanguard group inc
7.56%
5,040,150
SC 13G
Feb 04, 2022
blackrock inc.
5.2%
3,489,312
SC 13G
Feb 16, 2021
andreessen horowitz fund iv, l.p.
2.5%
1,394,563
SC 13G

Recent SEC filings of Accolade

View All Filings
Date Filed Form Type Document
Sep 20, 2023
4
Insider Trading
Sep 20, 2023
4
Insider Trading
Sep 20, 2023
4
Insider Trading
Sep 20, 2023
4
Insider Trading
Sep 19, 2023
144
Notice of Insider Sale Intent
Sep 19, 2023
144
Notice of Insider Sale Intent
Sep 19, 2023
144
Notice of Insider Sale Intent
Sep 13, 2023
4
Insider Trading
Sep 13, 2023
4
Insider Trading
Sep 13, 2023
4
Insider Trading

Peers (Alternatives to Accolade)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.7T
383.9B
-8.76% 20.36%
28.27
6.98
-0.93% -4.89%
2.3T
211.9B
-3.97% 33.32%
32.43
11.07
6.88% -0.52%
1.7T
289.5B
-3.71% 34.42%
27.32
5.75
4.10% -15.36%
1.3T
538.0B
-5.89% 10.73%
100.29
2.44
10.73% 12.62%
MID-CAP
1.5B
9.9B
-23.08% -30.83%
56.73
0.15
24.14% 106.11%
774.7M
246.5M
-11.19% 2.45%
-4.87
3.14
6.65% -174.04%
SMALL-CAP
1.6B
2.2B
-7.05% 17.79%
11.36
0.73
38.20% -10.10%
1.6B
627.1M
-7.75% -16.43%
-1.08
2.5
-0.20% -204.67%
1.2B
56.2M
23.62% -56.02%
-1.43
21.5
40.31% -12.26%
979.4M
543.3M
-12.64% 17.77%
-674.53
1.8
31.74% 78.13%
618.7M
356.8M
-22.36% -33.33%
-2.2
1.73
-23.03% 15.53%
485.3M
1.0B
-13.02% -37.07%
-18.36
0.47
-11.34% -107.10%
430.9M
453.3M
72.08% -71.84%
-0.35
0.95
-16.04% 55.90%
102.8M
13.7M
-13.56% -76.85%
-0.61
7.53
413.65% 52.51%

Accolade News

Best Stocks
Analyst Expresses Confidence in Accolade with Increased Price ....
Best Stocks,
4 hours ago
Defense World
Seeking Alpha
Wall Street Breakfast: The Week Ahead.
Seeking Alpha,
33 hours ago
Marketscreener.com
The Motley Fool

Returns for ACCD

Cumulative Returns on ACCD

-34.9%


3-Year Cumulative Returns

Risks for ACCD

What is the probability of a big loss on ACCD?

84.7%


Probability that Accolade stock will be more than 20% underwater in next one year

79.4%


Probability that Accolade stock will be more than 30% underwater in next one year.

55.9%


Probability that Accolade stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ACCD drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Accolade was unfortunately bought at previous high price.

Drawdowns

Financials for Accolade

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue2.1%370,840,000363,142,000357,873,000350,377,000336,022,000310,021,000275,497,000230,491,000193,991,000170,358,000155,567,000146,775,000139,638,000132,507,000117,421,333116,828,000115,052,00094,811,000
Operating Expenses-48.6%322,453,000627,751,000628,562,000559,394,000579,071,000266,727,000223,122,000243,564,000168,785,000123,462,000110,778,000108,142,000106,675,000107,026,000111,116,000107,566,000106,524,00088,220,000
  S&GA Expenses-0.6%98,532,00099,113,00099,204,00098,797,00097,870,00086,765,00073,004,00057,032,00040,904,00033,711,00030,688,00029,968,00029,703,00030,050,00030,936,00030,556,00030,648,00023,456,000
EBITDA100.0%--415,257,000-415,505,000-350,175,000-379,660,000-85,225,000-68,857,000-121,113,000-68,672,000-40,140,000-36,861,000-38,124,000-38,618,000-40,329,000-54,629,333-50,618,000-52,476,000-44,441,000
EBITDA Margin100.0%--1.14-1.16-1.00-1.13-0.27-0.25-0.53-0.35-0.24-0.24-0.26-0.28-0.30-0.47-0.43-0.46-0.47
Interest Expenses0%1,640,0001,640,0001,589,0001,648,0001,648,000930,000930,000204,0001,761,0002,296,0002,847,0003,384,0002,376,0002,391,0002,386,6672,402,0002,404,0002,609,000
Earnings Before Taxes66.6%-154,871,000-463,274,000-463,484,000-397,861,000-426,796,000-128,763,000-102,876,000-145,270,000-85,414,000-50,648,000-47,900,000-49,619,000-49,278,000-51,236,000-65,569,333-61,784,000-63,520,000-56,441,000
EBT Margin100.0%--1.28-1.30-1.14-1.27-0.42-0.37-0.63-0.44-0.30-0.31-0.34-0.35-0.39-0.56-0.53-0.55-0.60
Net Income66.2%-155,237,000-459,650,000-463,773,000-401,398,000-417,239,000-123,124,000-93,294,000-132,392,000-85,399,000-50,652,000-48,065,000-49,767,000-49,422,000-51,365,000-65,634,666-61,858,000-63,612,000-56,496,000
Net Income Margin100.0%--1.27-1.30-1.15-1.24-0.40-0.34-0.57-0.44-0.30-0.31-0.34-0.35-0.39-0.56-0.53-0.55-0.60
Free Cashflow100.0%--42,810,000-42,555,000-59,513,000-67,523,000-64,871,000-52,458,000-43,104,000-46,972,000-27,223,000-48,238,000-40,432,000-29,139,000-37,562,000-35,269,333-42,932,000-67,956,000-17,723,000
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q1
Assets-3.0%8769039149329441,2861,2631,27089147646726712073.0066.00
  Current Assets-4.8%34836636637537840940841845345444524397.0049.0047.00
    Cash Equivalents-5.7%30332132633133636636638432643441922278.0033.0043.00
  Net PPE12.5%17.0015.0014.0012.0012.0012.0012.0012.0012.009.0010.0012.0013.0014.0015.00
  Goodwill0%2782782782782785785806.003664.004.004.004.004.00-
Liabilities-1.8%42242942842541043047553645485.0079.0075.0015497.0082.00
  Current Liabilities-5.6%11311911711395.0011218524916779.0073.0069.0075.0070.0057.00
Shareholder's Equity-4.1%454474486506535856789734437391388192---
  Retained Earnings-4.0%-992-954-923-883-837-494-460-482-420-371-366-350-334-320-269
  Additional Paid-In Capital1.3%1,4471,4281,4101,3901,3721,3501,2491,21685776275554268.0064.0039.00
Shares Outstanding3.0%75.0073.0072.0072.0070.0067.0065.0064.0058.0056.0052.0033.008.006.005.00
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations27.5%-29,531-40,705-40,430-57,160-65,197-62,350-49,670-40,521-44,529-25,232-45,892-37,200-25,684-34,247-31,977-40,804-67,520-16,548
  Share Based Compensation-7.0%67,53372,64481,92182,39284,65372,93949,09333,66215,9929,5767,4176,0355,8256,0026,5276,6625,7445,721
Cashflow From Investing-29.1%-9,333-7,228-5,347-2,71563,827-263,613-263,572-264,812-330,597-2,423-2,778-3,664-3,950-3,521-3,566-2,540-436-3,118
Cashflow From Financing93.0%6,1063,1635,4326,50511,490257,932260,286467,225622,952428,384427,954239,04581,25928,22231,4815,8021,38048,833

ACCD Income Statement

2023-05-31
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
May 31, 2023
May 31, 2022
Condensed Consolidated Statements of Operations  
Revenue$ 93,226$ 85,528
Cost of revenue, excluding depreciation and amortization54,20347,615
Operating expenses:  
Product and technology25,89926,817
Sales and marketing25,03325,614
General and administrative16,08020,238
Depreciation and amortization11,64011,576
Goodwill impairment 299,705
Total operating expenses78,652383,950
Loss from operations(39,629)(346,037)
Interest income (expense), net921(634)
Other income (expense)390(50)
Loss before income taxes(38,318)(346,721)
Income tax benefit (expense)(91)3,899
Net loss$ (38,409)$ (342,822)
Net loss per share, basic$ (0.52)$ (4.92)
Net loss per share, diluted$ (0.52)$ (4.92)
Weighted-average common shares outstanding, basic73,179,99469,738,638
Weighted-average common shares outstanding, diluted73,179,99469,738,638

ACCD Balance Sheet

2023-05-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
May 31, 2023
Feb. 28, 2023
Current assets:  
Cash and cash equivalents$ 302,870$ 321,083
Accounts receivable, net22,53923,435
Unbilled revenue3,7603,260
Current portion of deferred contract acquisition costs3,9334,022
Prepaid and other current assets15,37214,149
Total current assets348,474365,949
Property and equipment, net16,60814,763
Operating lease right-of-use assets28,08029,525
Goodwill278,191278,191
Intangible assets, net192,829203,202
Deferred contract acquisition costs9,6799,815
Other assets1,8461,624
Total assets875,707903,069
Current liabilities:  
Accounts payable5,46110,155
Accrued expenses and other current liabilities13,78211,744
Accrued compensation27,62839,346
Due to customers14,76115,694
Current portion of deferred revenue44,18935,191
Current portion of operating lease liabilities6,9157,284
Total current liabilities112,736119,414
Loans payable, net of unamortized issuance costs282,742282,323
Operating lease liabilities25,74127,189
Other noncurrent liabilities168203
Deferred revenue142154
Total liabilities421,529429,283
Commitments and Contingencies (note 10)
Stockholders' equity  
Common stock par value $0.0001; 500,000,000 shares authorized; 75,264,400 and 73,089,075 shares issued and outstanding at May 31, 2023 and February 28, 2023, respectively87
Additional paid-in capital1,446,8731,428,073
Accumulated deficit(992,703)(954,294)
Total stockholders' equity454,178473,786
Total liabilities and stockholders' equity$ 875,707$ 903,069
Rajeev Singh
2350
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.